Search

everythinglearnresearchcommunity

for

Search:↓

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Ayurvedic treatment effectively manages alopecia areata with fewer side effects and relapses.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Botulinum neurotoxin injections into the pelvic muscles successfully prevented priapism relapse for over six months.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

Patients chose Chinese herbal medicine for safety, relapse prevention, and as an alternative to conventional treatments, but found preparation burdensome.

A girl with a rare syndrome had successful hair loss treatment with no relapse after 4 years.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Follicular unit extraction successfully restored hair growth in a leprosy patient without disease relapse.

New biomarkers and targets for breast cancer treatment were identified to help prevent relapse and metastasis.

The conclusion is that surgical removal of solitary fibrofolliculoma is effective with no relapses, and diagnosis requires a biopsy due to varied symptoms.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Intradermal PRP significantly improved melasma in dark skin, with lasting results and no relapse after 3 months.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.